Alistair Macdonald and Michael Gibertini, Ph.D., have been promoted to key roles within the C-suite at INC Research. Mr. Macdonald, who has served as chief operating officer since January 2013, has been promoted to president and chief operating officer, and Dr. Gibertini, president and general manager, Central Nervous System (CNS) Clinical Development, has been appointed to the newly-created role of president, Clinical Development to lead the company’s therapeutic offerings globally.   &#8...